Company intelligence / Profile preview
Citranvi Biosciences
Chapel Hill, North Carolina, United Statescitranvi.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Citranvi Biosciences has developed a proprietary multimeric protein vaccine platform licensed from the US Department of Defense, aiming to create first-in-class vaccines against human cytomegalovirus and Epstein-Barr virus. Both lead candidates are pre-clinical; no clinical trial results have been reported yet. The company’s approach has shown synergistic increases in neutralizing antibodies in preclinical studies using combinations of distinct proteins within a single vaccine formulation.[4]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Recombinant protein vaccines (multimeric protein technology)Subunit vaccineStructure-based vaccine design
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) – exclusive worldwide license partner on herpesvirus vaccine technology developed at Uniformed Services University/US DoD.[4]
Beyond the preview
Go deeper on Citranvi Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Citranvi Biosciences.